Other highlights in the June 16 JNCI

lid target for the treatment of gastric cancer.

Contact: Laura Sussman, Communications Office, M. D. Anderson Cancer Center, 713-745-2457, lsussman@mdanderson.org

Study Elucidates Molecular Interactions of Bone Sialoprotein in Cancer Cell Invasion

Although bone sialoprotein (BSP) is overexpressed in many malignant tissues, including breast, lung, prostate, and thyroid cancers, its role in tumor progression has remained unknown. In a new study, Abdullah Karadag, M.D., Ph.D., of the National Institute of Dental and Craniofacial Research in Bethesda, Md., and colleagues looked into whether BSP's interaction with other molecules enhances the invasiveness of cancer cells. They found that when BSP and two other molecules--matrix metalloproteinase 2 and integrin alphavbeta3--form a cell-surface trimolecular complex, cancer cells appear to become more invasive.

Contact: Robert Kuska, National Institute of Dental and Craniofacial Research, 301-594-7560, kuskar@mail.nih.gov

Also in the June 16 JNCI:

  • Review: Ductal Carcinoma In Situ, Complexities and Challenges (Leonard et al.)
  • Study Investigates Tamoxifen Resistance and Possible Way to Reverse It: http://www.eurekalert.org/emb_releases/2004-06/jotn-sib061004.php
  • Calcium Supplements Associated with Decreased Risk of Large Bowel Polyps: http://www.eurekalert.org/emb_releases/2004-06/jotn-csa061004.php


  • Contact: Sarah L. Zielinski
    Journal of the National Cancer Institute

    Page: 1 2

    Related biology news :

    1. Other highlights in the September 1 JNCI
    2. Other highlights in the August 18 JNCI
    3. Other highlights in the August 4 JNCI
    4. Other highlights in the July 7 JNCI
    5. Other Highlights in the June 2 JNCI
    6. Other highlights in the May 19 JNCI
    7. Other highlights in the May 5 JNCI
    8. Other highlights of the March 17 issue of JNCI
    9. Other highlights in the March 3 issue of JNCI
    10. Other highlights in the February 18 issue of JNCI
    11. Other highlights in the February 4 issue of JNCI

    Post Your Comments:

    (Date:10/3/2019)... ... October 02, 2019 , ... Personalized Stem Cells, ... patient in an FDA approved clinical trial for stem cell treatment of knee ... formation of the company as a subsidiary of VetStem Biopharma. , PSC CEO, Michael ...
    (Date:9/30/2019)... ... September 30, 2019 , ... ... mesenchymal stem/stromal cell (hMSC) biomanufacturing systems, today announced it has received patent ... product formats (patent number AU 2015259373). This new patent adds intellectual property ...
    (Date:9/25/2019)... ... , ... Deep Science Ventures (DSV), a new paradigm for applied ... of cancer research. , Deep Science Ventures was founded to create a better method ... from the start, both at the industry and biological level. , Through their ...
    Breaking Biology News(10 mins):
    (Date:9/30/2019)... (PRWEB) , ... September 30, 2019 , ... ... materials science newsletter from Rigaku Corporation , is now available online on ... to X-ray based materials science, including X-ray diffraction, fluorescence and imaging, and presents ...
    (Date:9/24/2019)... (PRWEB) , ... September 24, ... ... provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, ... a clinical-stage biopharmaceutical company focused on the development of therapies to treat ...
    (Date:9/24/2019)... ... , ... In the past three years, the National Science Foundation (NSF) has ... School of Mines & Technology that expands human understanding of the microbial world. ... slimy and yet strong layer which is commonly known as a biofilm. , The ...
    (Date:9/17/2019)... ... 2019 , ... Tucker, a Labrador retriever, was just a puppy when he ... and lame on his right hip and elbow. At one year of age, Tucker ... case the vet had seen.” He was prescribed pain medications, both oral and injectable, ...
    Breaking Biology Technology:
    Cached News: